Projects per year
Fingerprint
Dive into the research topics where Peter Cole is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Identification of novel biomarkers and therapeutic strategies in chemobrain.
Jang, M.-H. M. (PI) & Cole, P. (CoPI)
6/26/24 → 5/31/25
Project: Research project
-
Characterization of brain dysfunction during development in survivors of childhood acute lymphoblastic leukemia
Sussman, E. E. S. (PI), Wagshul, M. E. (CoPI) & Cole, P. (CoPI)
3/1/20 → 2/28/25
Project: Research project
-
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL
Cole, P. (CoPI) & Sands, S. A. (CoPI)
9/17/18 → 8/31/23
Project: Research project
-
Markers of Cognitive Decline During Treatment for Childhood ALL
Cole, P. (PI) & Sands, S. A. (CoPI)
9/17/15 → 8/31/16
Project: Research project
-
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
Cole, P. (CoPI)
6/1/14 → 6/30/20
Project: Research project
-
Feasibility of Utilizing a Brief Neurocognitive Battery in 3-Year-Old Patients During Treatment for Acute Lymphoblastic Leukemia
Ramjan, S., Cole, P. D., Blair-Thies, M., Silverman, L. B., Fredrickson, A., Schembri, A., Welch, J. J. G., Kahn, J., Kelly, K. M., Tran, T. H., Michon, B., Gennarini, L. & Sands, S. A., Mar 2025, In: Pediatric Blood and Cancer. 72, 3, e31469.Research output: Contribution to journal › Article › peer-review
Open Access -
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment
Janelsins, M. C., Van Dyk, K., Hartman, S. J., Koll, T. T., Cramer, C. K., Lesser, G. J., Barton, D. L., Mustian, K. M., Wagner, L. I., Ganz, P. A., Cole, P. D., Bakos, A., Root, J. C., Hardy, K., Magnuson, A., Ferguson, R. J., McDonald, B. C., Saykin, A. J., Gonzalez, B. D. & Wefel, J. S. & 15 others, , Feb 1 2025, In: Journal of the National Cancer Institute. 117, 2, p. 217-228 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial
Daw, S., Cole, P. D., Hoppe, B. S., Hodgson, D., Beishuizen, A., Garnier, N., Buffardi, S., Mascarin, M., Lissat, A., Mauz-Körholz, C., Krajewski, J., Akyol, A., Crowe, R., Anderson, B., Xu, Y., Drachtman, R. A., Kelly, K. M., Leblanc, T. & Harker-Murray, P., 2025, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis
Driessen, J., de Wit, F., Herrera, A. F., Zinzani, P. L., LaCasce, A. S., Cole, P. D., Moskowitz, C. H., García-Sanz, R., Fuchs, M., Müller, H., Borchmann, P., Santoro, A., Schöder, H., Zijlstra, J. M., Hutten, B. A., Moskowitz, A. J. & Kersten, M. J., Jun 11 2024, In: Blood Advances. 8, 11, p. 2740-2752 13 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Exposure–Response and Subgroup Analyses to Support Body Weight–Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-risk Classical Hodgkin Lymphoma
Zhang, Z., Zhang, D., Guo, W., Fenton, K., Narayanan, S., Jain, S., Jiang, J., Castellino, S. M., Kelly, K. M., Cole, P. D., Keller, F. G., Garg, A. & Chia, Y. L., Aug 1 2024, In: Clinical Cancer Research. 30, 15, p. 3273-3281 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations